HISTORY how we got here

1
HISTORYhow we got here

• 1997 Developed the 1A Survey and began data
  basing the incidence of disease and illness
  caused by or associated with Serotonin deficiency
  in weight patients coming into the program.

2
HISTORYhow we got here

• 1998 Refined approach and developed new drug /
  amino acid combinations with the assistance of
  the database.

3
HISTORYhow we got here

• January 1999 Began installing programs in other
  medical clinics
• 1999 By the year end, we had developed an
  amino acid only approach to dealing with weight
  loss.

4
HISTORYhow we got here

• 2000 In the spring we began doing clinic
  training seminars. There is a learning curve
  here, without training proper results are not
  obtained in clinics and programs.
• 2000 In response to problems encountered with
  patients stopping phentermine we started working
  with cysteine.

5
HISTORYhow we got here

• 2001 Hundreds of neurotransmitter labs were
  performed to calibrate the system.
• 2001 In the fall began Mucuna (L-dopa) work.

6
HISTORYhow we got here

• 2004 concept of The Phase 3 Response brought
  in.
• 2005 identified need for tyrosine base with
  L-dopa
• Current under wraps pending patent applications

7
HISTORYhow we got here

• Currently over 800 clinical practices treating
  patients with these methods each month.

8
Education is the key

• Newsletters and mailings
• (3,900 clinics)

9
Education is the key

• Telephone Tech Support
• NeuroResearch 877-626-2220

10
Education is the key

• Programs that have been trained in seminar are
  using 20 to 30 times more product versus those
  that simply start on their own without training.
• 20 to 30 times more patients
• 20 to 30 times more revenues
• 4 to 6 bottles a month versus 60 to 120 bottles a
  month.